Pharmalicensing
Pharmalicensing is the leading global resource for partnering, licensing, and business development within the life science and biopharmaceutical industries.
With more than twelve years dedicated to building relationships and facilitating successful partnerships, Pharmalicensing provides the connection across all aspects of life science between companies, research laboratories and universities.
|
 View Sample from this Publisher
Adobe Acrobat required
|
List of reports from Pharmalicensing
|
|
$995.00
|
The China Pharmaceutical Market: A Strategic Opportunity Analysis
1/1/2007 | published by: Pharmalicensing
... has become an attractive destination for R&D as new opportunities have emerged following its WTO (World Trade Organization) accession. Development has accelerated both industrially and scientifically, and today the Chinese pharmaceutical market is worth around ...
|
more...
|
$1,200.00
|
|
|
$2,695.00
|
Partneringdesk Deals and Alliances In Oncology
6/1/2006 | published by: Pharmalicensing
... purchase (USPs and key questions answered): Partneringdesk Deals and alliances in oncology provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the ...
|
more...
|
$2,495.00
|
|
|
$2,495.00
|
Partneringdesk Deals and Alliances In Metabolic Diseases
6/1/2006 | published by: Pharmalicensing
... (USPs and key questions answered) Partneringdesk Deals and alliances in metabolic diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the ...
|
more...
|
$2,495.00
|
Partneringdesk Deals and Alliances In Musculoskeletal Diseases
6/1/2006 | published by: Pharmalicensing
... and key questions answered) Partneringdesk Deals and alliances in musculoskeletal diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the assessment ...
|
more...
|
$2,495.00
|
|
|
$2,495.00
|
Partneringdesk Deals and Alliances In Dermatological Diseases
6/1/2006 | published by: Pharmalicensing
... (USPs and key questions answered) Partneringdesk Deals and alliances in dermatological diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the ...
|
more...
|
$2,495.00
|
|
|
$2,495.00
|
Partneringdesk Deals and Alliances In Respiratory Diseases
6/1/2006 | published by: Pharmalicensing
... and key questions answered) Partneringdesk Deals and alliances in respiratory diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the assessment ...
|
more...
|
$2,495.00
|
Partneringdesk Deals and Alliances In Hospital, Accident and Trauma
6/1/2006 | published by: Pharmalicensing
... format. The report contains: fully categorized deal overviews financial information where disclosed company profiles of the top 25 dealmakers in the report specialized indexes by company, development stage, deal type and industry sector. wider coverage ...
|
more...
|
$2,495.00
|
Partneringdesk Deals and Alliances In Infectious Diseases
6/1/2006 | published by: Pharmalicensing
... Reasons to purchase (USPs and key questions answered) Partneringdesk Deals and alliances in infectious diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and ...
|
more...
|
$2,495.00
|
|
|
$2,495.00
|
Partneringdesk Deals and Alliances In Gastrointestinal Diseases
6/1/2006 | published by: Pharmalicensing
... (USPs and key questions answered) Partneringdesk Deals and alliances in gastrointestinal diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in: the ...
|
more...
|
$2,495.00
|
Partneringdesk Deals and Alliances In Sensory And Dental Diseases
6/1/2006 | published by: Pharmalicensing
... format. Reasons to purchase (USPs and key questions answered) Partneringdesk deals and alliances in sensory and dental diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and ...
|
more...
|
$2,495.00
|
India: Pharmaceutical and Biotechnology Opportunities
4/1/2006 | published by: Pharmalicensing
... overview of the Indian pharma and biotech market, and answers the following key questions: Who are the key players in the Indian pharmaceutical market? How has the Indian regulatory environment changed? What R&D collaborative opportunities ...
|
more...
|
$1,200.00
|
Business Opportunities in China: The Impact of the WTO - 2nd Edition
3/1/2006 | published by: Pharmalicensing
... competitiveness of the Chinese pharmaceutical industry in the international market The R&D and business opportunities for pharmaceutical firms considering alliances in China Significant points for consideration for companies looking to capture business opportunities in China.
|
more...
|
$795.00
|
Partneringreview 2006 - Full Report
2/1/2006 | published by: Pharmalicensing
... the finances of different deal types compare? Want to know what the early, clinical and late stage developments are? Interested in new merger and acquisition activity over 2005? Curious about financing investments from lead investors? ...
|
more...
|
$3,995.00
|
Partneringreview 2006 - Company Deal Index (Volume 1)
2/1/2006 | published by: Pharmalicensing
... A clear and easy way to see the activities of any company. Every deal by every company listed alphabetically. Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, ...
|
more...
|
$2,495.00
|
Partneringreview 2006 - Therapy Area (Volume 2)
2/1/2006 | published by: Pharmalicensing
... deal announcements in therapeutic areas - oncology, infectious disease, cardiovascular, circulatory, central nervous system, autoimmune, inflammation, metabolism, respiratory, gastrointestinal, musculoskeletal, sensory organ, oral health, genitourinary, gynecology, dermatology, blood system, lymphatic system, and accident/hospital/trauma. Each sector ...
|
more...
|
$2,495.00
|
Partneringreview 2006 - Financings (Volume 3)
2/1/2006 | published by: Pharmalicensing
... way to see the investment activities of any company. Every deal by every company listed alphabetically. Every financing - grant/award deal is fully categorized, includes a detailed description, and includes financials such as headline value, ...
|
more...
|
$2,495.00
|
Partneringreview 2006 - Stage of Development (Volume 4)
2/1/2006 | published by: Pharmalicensing
... 2,600 deal announcements from discovery stage deals to marketed - the full list of stages covered - discovery, lead molecule, preclinical, phase I, phase I/II, phase II, phase II/III, pre-registration, regulatory approval, marketing and formulation ...
|
more...
|
$2,495.00
|
Partneringreview 2006 - Deal Type (Volume 5)
2/1/2006 | published by: Pharmalicensing
... announcements by deal type including licensing, cross license, technology access, sublicense, evaluation, letter of intent, co-marketing, co-promotion, contract marketing, contract manufacture, marketing, promotion, OEM, purchase, supply, distribution, manufacturing, collaborative R&D, CRADA, co-development, contract development, contract ...
|
more...
|
$2,495.00
|
Partneringreview 2006 - Industry Sector (Volume 6)
2/1/2006 | published by: Pharmalicensing
... deal announcements in nine industry sectors - pharmaceutical, biotechnology, discovery, research tools, diagnostic, medical device, bioinformatics, drug delivery, and academic/government. Each sector is further divided to analyze deals by company, therapy area and stage of ...
|
more...
|
$2,495.00
|
|
Join Alert Me now!Receive bi-weekly email alerts on new market research Sign up today!
|